Über uns
Dr Megan Baldwin was appointed CEO and Managing Director of Opthea Limited (formerly Circadian Technologies), in February 2014. Dr Baldwin has over 20 years of experience focussing on angiogenesis and therapeutic strategies for cancer and ophthalmic indications. Dr Baldwin joined the company in 2008 and since then has held various positions, including Head of Preclinical R&D and Chief Executive Officer of Opthea Pty Ltd, which at that time operated as a 100% owned subsidiary of Circadian, developing OPT-302 (formerly VGX-300) for the treatment of wet age-related macular degeneration. Prior to Opthea, she was employed at Genentech (now Roche), the world leader in the field of angiogenesis-based therapies for cancer and other diseases. Her experience included several years as a researcher in the group of leading angiogenesis expert Napoleone Ferrara, before moving to Genentech’s commercial division and having responsibility for corporate competitive intelligence activities. In these roles, she developed extensive commercial and scientific knowledge in the field of anti-angiogenic and oncology drug development. She holds a PhD in Medicine from the University of Melbourne, having conducted her doctoral studies at the Ludwig Institute for Cancer Research and is a member of the Australian Institute for Company Directors and a board member of Ausbiotech.
Activity
-
Looking forward to a new role in assisting Mayne Pharma with their Investor Relations program as we prepare for our FY24 Results on 23 August 2024. I…
Looking forward to a new role in assisting Mayne Pharma with their Investor Relations program as we prepare for our FY24 Results on 23 August 2024. I…
Liked by Megan Baldwin
-
In April I sent a company-wide note with the subject line “I hate meetings.” Unsurprisingly, it’s our most-read internal communication to date. My…
In April I sent a company-wide note with the subject line “I hate meetings.” Unsurprisingly, it’s our most-read internal communication to date. My…
Liked by Megan Baldwin
-
This story is a great summary of the most recent Opthea highlights. A big thank you to the editors of Eyes On Eyecare for sharing this article…
This story is a great summary of the most recent Opthea highlights. A big thank you to the editors of Eyes On Eyecare for sharing this article…
Liked by Megan Baldwin
Erleben Sie
-
Opthea Limited
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Bildung
Volunteer Experience
-
Volunteer
Monash Medical Centre
- Present 28 years
Honors & Awards
-
Emerging Woman in Leadership Award
BioMelbourne Network
Languages
-
Englisch
Native or bilingual proficiency
Organizations
-
Ausbiotech
Board Member
- PresentThe Ausbiotech Board of Directors are elected as representatives of AusBiotech to provide strategic guidance and corporate management-related policies. Each Board member brings extensive experience of working in the Australian biotechnology industry, representing technical, commercial and policy expertise.
-
Veski
Member Veski Connection
- Present
More activity by Megan
-
📢 AusBiotech welcomes more new members in the second quarter As the national peak body for life sciences and Australian life sciences innovators…
📢 AusBiotech welcomes more new members in the second quarter As the national peak body for life sciences and Australian life sciences innovators…
Liked by Megan Baldwin
-
Delighted to have been appointed Chair of AusBiotech, Australia's peak industry body for biotechnology.
Delighted to have been appointed Chair of AusBiotech, Australia's peak industry body for biotechnology.
Liked by Megan Baldwin
-
The Hon. Mark Butler MP launches new biotech company targeting hard-to-treat cancers (BiotechDispatch 18.06.2024): Minister for Health and Aged…
The Hon. Mark Butler MP launches new biotech company targeting hard-to-treat cancers (BiotechDispatch 18.06.2024): Minister for Health and Aged…
Liked by Megan Baldwin
-
I’m delighted to be appointed as Chair of AusBiotech and am grateful to my fellow Board members for their invitation and confidence. Australia’s life…
I’m delighted to be appointed as Chair of AusBiotech and am grateful to my fellow Board members for their invitation and confidence. Australia’s life…
Liked by Megan Baldwin
-
Congrats Jason Ehrlich for winning the “Summit of Excellence” Award - Industry at CTS 2024. This was a unanimous decision by the award committee…
Congrats Jason Ehrlich for winning the “Summit of Excellence” Award - Industry at CTS 2024. This was a unanimous decision by the award committee…
Liked by Megan Baldwin
-
It was emotional and truly inspiring to reconnect with my former classmates and friends from all over the world for our 15-year INSEAD MBA reunion in…
It was emotional and truly inspiring to reconnect with my former classmates and friends from all over the world for our 15-year INSEAD MBA reunion in…
Liked by Megan Baldwin
Other similar profiles
Gemeinsame Artikel erkunden
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Megan Baldwin in Australia
7 others named Megan Baldwin in Australia are on LinkedIn
See others named Megan Baldwin